BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  SENS Research Foundation Receives $1M Bitcoin Donation From Pineapple Fund

  SENS Research Foundation announced today the receipt of a $1M bitcoin donation from the Pineapple Fund.

  December 18, 2017

   · 

  1 min read
• Drug Development

  Targovax Announces That TG02 Has Passed the Initial Safety Review in the First-in-Man Clinical Trial in Colorectal Cancer

  Targovax today announces that TG02 has passed the initial planned safety review in the phase Ib clinical mechanism-of-action trial evaluating TG02, and TG02 in combination with the checkpoint inhibitor KEYTRUDA, in patients with confirmed RAS-mutated colorectal cancer.

  December 18, 2017

   · 

  4 min read
• 

  Business

  Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant Patients

  The collaboration will evaluate therapeutic approaches using SENS-401 in combination with cochlear implants, with preclinical studies initiating in 2018, and potential clinical trials to begin as soon as 2019.

  December 18, 2017

   · 

  6 min read
• Deals

  Recordati: Acquires Transipeg, Transipeglib and Colopeg for the French Market

  The 2016 net sales of the products in France amount to around € 10 million.

  December 18, 2017

   · 

  2 min read
• Apeiron Announces Publication of Clinical Data With Anti-GD2 Antibody Demonstrating Efficacy in Relapsed & Refractory High-Risk Neuroblastoma

  The study successfully explored a GD2 antibody administration schedule of 10 day continuous slow infusion, to limit treatment-associated neuropathic pain, while preserving efficacy.

  December 18, 2017

   · 

  4 min read
• Drug Development

  BeiGene Initiates Pivotal Trial of PARP inhibitor Pamiparib (BGB-290) in China in Patients With Ovarian Cancer

  BeiGene today announced that the first patient was dosed in a pivotal Phase 2 clinical trial of pamiparib in Chinese patients with advanced ovarian cancer.

  December 18, 2017

   · 

  4 min read
• Business

  RadNet and MemorialCare Announce a Joint Venture, Creating the Largest, Most Accessible Imaging Network Serving Orange and Los Angeles Counties, California

  RadNet today announced that they have formed a joint venture.

  December 18, 2017

   · 

  4 min read
• Drug Development

  Achillion Announces ACH-4471 Granted Orphan Drug Designation for the Treatment of C3 Glomerulopathy (C3G) and the Initiation of a Phase 1 Extended-Release Bioavailability Study

  This designation may provide, under specified conditions, for a seven-year marketing exclusivity period, as well as certain incentives, including federal grants, tax credits and a waiver of PDUFA filing fees.

  December 18, 2017

   · 

  6 min read
• Pharm Country

  Madrigal Pharma Announces Proposed Public Offering of Common Stock

  Madrigal Pharma today announced that it has commenced an underwritten public offering of $100M of its common stock.

  December 18, 2017

   · 

  3 min read
• Bio NC

  BioDelivery Sciences Announces Notice of Allowance of Patent Strengthening Patent Protection on BELBUCA to 2032

  The patent covers the method of using BioErodible MucoAdhesive for the treatment of chronic pain.

  December 18, 2017

   · 

  3 min read